Submission date
03/06/2005
Registration date
08/07/2005
Last edited
09/03/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Infections and Infestations
Retrospectively registered
? Protocol not yet added
? SAP not yet added
Results added
? Raw data not yet added
Study completed

Plain English Summary

Not provided at time of registration

Study website

Contact information

Type

Scientific

Contact name

Dr Lut Van Damme

ORCID ID

Contact details

1611 N Kent Street
Suite 806
Arlington
VA
22209
United States of America
+1 703 276 4020
lvandamme@conrad.org

Additional identifiers

EudraCT/CTIS number

IRAS number

ClinicalTrials.gov number

NCT00153777

Protocol/serial number

C03-090

Study information

Scientific title

Acronym

Study hypothesis

Effect on vaginal male-to-female transmission of HIV/Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT). Null hypotheses (of no effect) are tested.

Ethics approval(s)

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

International

Study setting(s)

Not specified

Study type

Prevention

Patient information sheet

Condition

HIV infection

Intervention

Randomized to 6% CS gel or Placebo gel; both arms receive condoms and safer sex counseling. Any curable sexually transmitted infection (STI) or urinary tract infection (UTI) will be treated. Referrals for other conditions. Three monthly gynecological exam with STI testing.

Intervention type

Drug

Pharmaceutical study type(s)

Phase

Phase III

Drug/device/biological/vaccine name(s)

Cellulose sulfate

Primary outcome measure

HIV infection (incident)

Secondary outcome measures

NG infection; CT infection

Overall study start date

13/06/2005

Overall study end date

31/01/2007

Reason abandoned (if study stopped)

Eligibility

Participant inclusion criteria

Healthy women at risk of HIV infection through their own sexual behavior.

Participant type(s)

Patient

Age group

Adult

Sex

Female

Target number of participants

2574

Participant exclusion criteria

HIV positive women or at risk of HIV through other transmission routes; pregnant women.

Recruitment start date

13/06/2005

Recruitment end date

31/01/2007

Locations

Countries of recruitment

Benin, Burkina Faso, India, South Africa, Uganda, United States of America

Study participating centre

1611 N Kent Street
Arlington, VA
22209
United States of America

Sponsor information

Organisation

CONRAD (USA)

Sponsor details

1611 N Kent Street
Suite 806
Arlington
VA
22209
United States of America
+1 703 524 4744
lvandamme@conrad.org

Sponsor type

Government

Website

http://www.conrad.org

Funders

Funder type

Government

Funder name

US Agency for International Development (USAID): $12M

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Funder name

Bill and Melinda Gates Foundation (USA): $12M

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Individual participant data (IPD) sharing plan

IPD sharing plan summary

Not provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 31/07/2008 Yes No
Results article results 27/10/2010 Yes No

Additional files

Editorial Notes